# Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer

> **NCT02337712** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 198 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **RADIATION:** q.d. RT
- **RADIATION:** b.i.d.RT
- **DRUG:** etoposide and cisplatin

## Key facts

- **NCT ID:** NCT02337712
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-12
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02337712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02337712, "Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02337712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*